These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3118674)

  • 41. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
    Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
    Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation of suprasellar nonneoplastic cysts from cystic neoplasms by Gd-DTPA MRI.
    Hua F; Asato R; Miki Y; Okumura R; Hashimoto N; Kikuchi H; Konishi J
    J Comput Assist Tomogr; 1992; 16(5):744-9. PubMed ID: 1522267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 45. Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases.
    Ahmadi J; Meyers GS; Segall HD; Sharma OP; Hinton DR
    Radiology; 1995 Apr; 195(1):30-4. PubMed ID: 7892490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MR of corticotropin-secreting pituitary microadenomas.
    Colombo N; Loli P; Vignati F; Scialfa G
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1591-5. PubMed ID: 7985584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance imaging of acoustic neuromas: the role of gadolinium-DTPA.
    Stack JP; Ramsden RT; Antoun NM; Lye RH; Isherwood I; Jenkins JP
    Br J Radiol; 1988 Sep; 61(729):800-5. PubMed ID: 3179642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
    Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H
    Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients.
    Davis PC; Gokhale KA; Joseph GJ; Peterman SB; Adams DA; Tindall GT; Hudgins PA; Hoffman JC
    Radiology; 1991 Sep; 180(3):779-84. PubMed ID: 1871293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT.
    Krestin GP; Freidmann G; Fishbach R; Neufang KF; Allolio B
    J Comput Assist Tomogr; 1991; 15(1):104-10. PubMed ID: 1987177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic MRI with slow injection of contrast material for the diagnosis of pituitary adenoma.
    Hayashi S; Ito K; Shimada M; Tsubuku M; Kaneko I; Kogure T; Kusama K; Nanba T; Senoh A; Tsuchida S
    Radiat Med; 1995; 13(4):167-70. PubMed ID: 8539442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of pituitary macroadenomas with multidetector-row CT (MDCT): comparison with MR imaging.
    Miki Y; Kanagaki M; Takahashi JA; Ishizu K; Nakagawa M; Yamamoto A; Fushimi Y; Okada T; Mikuni N; Kikuta K; Hashimoto N; Togashi K
    Neuroradiology; 2007 Apr; 49(4):327-33. PubMed ID: 17200863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pituitary adenomas with parasellar invasion.
    Knosp E; Kitz K; Steiner E; Matula C
    Acta Neurochir Suppl (Wien); 1991; 53():65-71. PubMed ID: 1803887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images.
    Gao R; Isoda H; Tanaka T; Inagawa S; Takeda H; Takehara Y; Isogai S; Sakahara H
    Eur J Radiol; 2001 Sep; 39(3):139-46. PubMed ID: 11566239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
    Kobayashi S; Ikeda H; Yoshimoto T
    Neuroradiology; 1994 May; 36(4):298-302. PubMed ID: 8065575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJNR Am J Neuroradiol; 1990; 11(4):749-54. PubMed ID: 2114763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
    Semelka RC; Cumming MJ; Shoenut JP; Magro CM; Yaffe CS; Kroeker MA; Greenberg HM
    Radiology; 1993 Mar; 186(3):799-802. PubMed ID: 8381551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 59. Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT.
    Chang KH; Han MH; Roh JK; Kim IO; Han MC; Kim CW
    AJR Am J Roentgenol; 1990 Apr; 154(4):809-16. PubMed ID: 2107681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MRI of pituitary adenomas: the position of the normal pituitary gland.
    Sumida M; Uozumi T; Mukada K; Arita K; Kurisu K; Yano T; Onda J; Satoh H; Ikawa F
    Neuroradiology; 1994 May; 36(4):295-7. PubMed ID: 8065574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.